Is Senti Biosciences, Inc. (SNTI) a Buy, Sell, or Hold?
NASDAQ : SNTI
Senti Biosciences, Inc. — Insider Trades
$0.4038 USD
-$0.02 (-5.34%)
- Volume
- 190.19K
- Average Volume
- 254.06K
- Market Capitalization
- $12.57M
- P/E Ratio
- -0.21
- Dividend Yield
- 0.00%
- Price Target
- $6.00
- Year High
- $2.88
- Year Low
- $0.40
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.04
Insider Activity Summary (Last 12 Months)
Insiders Buying
22
Insiders Selling
12
Amount of Insider Selling
$118.31K
SNTI Insider Buying/Selling by Quarter
SNTI Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Rajangam Kanya | officer: Pres. & Chief Med. & Dev. Off. | 2026-03-09 | F-InKind | 0 | 2026-03-11 |
| Lu Timothy K | director, officer: CEO | 2026-03-09 | F-InKind | 0 | 2026-03-11 |
| Rajangam Kanya | officer: Pres. & Chief Med. & Dev. Off. | 2026-02-02 | F-InKind | 0 | 2026-02-03 |
| Lu Timothy K | director, officer: CEO | 2026-02-02 | F-InKind | 0 | 2026-02-03 |
| Baum Bryan Daniel | director | 2025-07-18 | A-Award | 1.95 | 2025-07-21 |
| Baum Bryan Daniel | director: | 2025-07-18 | 0 | 2025-07-21 | |
| Collins James J. | director | 2025-06-25 | A-Award | 2.05 | 2025-06-27 |
| Hsiung Feng | director | 2025-06-25 | A-Award | 2.05 | 2025-06-27 |
| Schulz Fran | director | 2025-06-25 | A-Award | 2.05 | 2025-06-27 |
| COOPERSTONE BRENDA | director | 2025-06-25 | A-Award | 2.05 | 2025-06-27 |
| Tang Donald F | director | 2025-06-25 | A-Award | 2.05 | 2025-06-27 |
| Mathers Edward T | director | 2025-06-25 | A-Award | 2.05 | 2025-06-27 |
| Celadon Partners SPV 24 | 10 percent owner | 2025-03-10 | C-Conversion | 0 | 2025-03-14 |
| Celadon Partners SPV 24 | 10 percent owner | 2025-03-10 | C-Conversion | 0 | 2025-03-14 |
| Celadon Partners SPV 24 | 10 percent owner | 2025-03-06 | 2.3 | 2025-03-13 | |
| Celadon Partners SPV 24 | 10 percent owner | 2025-03-06 | 2.25 | 2025-03-13 | |
| New Enterprise Associates 15, L.P. | 10 percent owner | 2025-03-10 | C-Conversion | 0 | 2025-03-12 |
| New Enterprise Associates 15, L.P. | 10 percent owner | 2025-03-10 | C-Conversion | 0 | 2025-03-12 |
| New Enterprise Associates 15, L.P. | 10 percent owner | 2025-03-06 | 0 | 2025-03-12 | |
| New Enterprise Associates 15, L.P. | 10 percent owner | 2025-03-06 | 0 | 2025-03-12 | |
| New Enterprise Associates 15, L.P. | 10 percent owner | 2025-03-06 | 0 | 2025-03-12 | |
| BAYER HEALTHCARE LLC | 10 percent owner | 2025-03-10 | C-Conversion | 0 | 2025-03-12 |
| BAYER HEALTHCARE LLC | 10 percent owner | 2025-03-10 | C-Conversion | 0 | 2025-03-12 |
| Mathers Edward T | director | 2025-03-07 | A-Award | 3.52 | 2025-03-11 |
| Rajangam Kanya | officer: Pres. & Chief Med. & Dev. Off. | 2025-03-10 | C-Conversion | 2.25 | 2025-03-11 |
| Rajangam Kanya | officer: Pres. & Chief Med. & Dev. Off. | 2025-03-10 | C-Conversion | 2.25 | 2025-03-11 |
| Schulz Fran | director | 2025-03-07 | A-Award | 3.52 | 2025-03-11 |
| Collins James J. | director | 2025-03-07 | A-Award | 3.52 | 2025-03-11 |
| Tang Donald F | director | 2025-03-07 | A-Award | 3.52 | 2025-03-11 |
| COOPERSTONE BRENDA | director | 2025-03-07 | A-Award | 3.52 | 2025-03-11 |
| Hsiung Feng | director | 2025-03-07 | A-Award | 3.52 | 2025-03-11 |
| Hsiung Feng | director: | 2025-03-07 | 0 | 2025-03-11 | |
| Cross John Harry III | officer: Chief Financial Officer | 2025-03-07 | A-Award | 3.52 | 2025-03-11 |
| Cross John Harry III | officer | 2025-03-03 | 0 | 2025-03-11 | |
| Rajangam Kanya | officer: Pres. & Chief Med. & Dev. Off. | 2025-03-06 | A-Award | 3.97 | 2025-03-10 |
| Rajangam Kanya | officer: Pres. & Chief Med. & Dev. Off. | 2025-03-07 | A-Award | 0 | 2025-03-10 |
| Lu Timothy K | director, officer: CEO and Interim PFO and PAO | 2025-03-06 | A-Award | 3.97 | 2025-03-10 |
| Lu Timothy K | director, officer: CEO and Interim PFO and PAO | 2025-03-07 | A-Award | 0 | 2025-03-10 |
| Lu Timothy K | director, officer: CEO | 2025-02-04 | S-Sale | 4.07 | 2025-02-06 |
| Lu Timothy K | director, officer: CEO | 2025-02-06 | S-Sale | 4.36 | 2025-02-06 |
| Rajangam Kanya | officer: Pres. & Chief Med. & Dev. Off. | 2025-02-04 | S-Sale | 4.07 | 2025-02-06 |
| Rajangam Kanya | officer: Pres. & Chief Med. & Dev. Off. | 2025-02-06 | S-Sale | 4.37 | 2025-02-06 |
| BAYER HEALTHCARE LLC | 10 percent owner | 2024-12-09 | P-Purchase | 2.3 | 2024-12-11 |
| BAYER HEALTHCARE LLC | 10 percent owner | 2024-12-09 | P-Purchase | 0 | 2024-12-11 |
| Tang Donald F | director | 2024-12-09 | A-Award | 6.52 | 2024-12-10 |
| Tang Donald F | director | 2024-12-09 | 0 | 2024-12-10 | |
| Schulz Fran | director | 2024-12-09 | A-Award | 6.52 | 2024-12-10 |
| Schulz Fran | director: | 2024-12-09 | 0 | 2024-12-10 | |
| Rajangam Kanya | officer: Pres. & Chief Med. & Dev. Off. | 2024-12-09 | A-Award | 2.3 | 2024-12-10 |
| Rajangam Kanya | officer: Pres. & Chief Med. & Dev. Off. | 2024-12-09 | A-Award | 2.25 | 2024-12-10 |
| Mathers Edward T | director | 2024-07-10 | A-Award | 0.31 | 2024-07-12 |
| Farokhzad Omid | director | 2024-07-10 | A-Award | 0.31 | 2024-07-12 |
| Collins James J. | director | 2024-07-10 | A-Award | 0.31 | 2024-07-12 |
| COOPERSTONE BRENDA | director | 2024-07-10 | A-Award | 0.31 | 2024-07-12 |
| Li Yvonne | officer | 2024-05-04 | 0 | 2024-05-09 | |
| Rajangam Kanya | officer: Chief Medical & Devt. Officer | 2024-02-01 | A-Award | 0.46 | 2024-02-02 |
| Rajangam Kanya | officer: Chief Medical & Devt. Officer | 2024-02-01 | A-Award | 0 | 2024-02-02 |
| Lu Timothy K | director, officer: CEO and President | 2024-02-01 | A-Award | 0 | 2024-02-02 |
| Lu Timothy K | director, officer: CEO and President | 2024-02-01 | A-Award | 0.46 | 2024-02-02 |
| KNOBELMAN DEBORAH | officer, other: Chief Financial Officer | 2024-02-01 | A-Award | 0.46 | 2024-02-02 |
| KNOBELMAN DEBORAH | officer, other: Chief Financial Officer | 2024-02-01 | A-Award | 0 | 2024-02-02 |
| Mathers Edward T | director | 2023-06-16 | A-Award | 0.99 | 2023-06-21 |
| Berland Susan D | director | 2023-06-16 | A-Award | 0.99 | 2023-06-21 |
| Collins James J. | director | 2023-06-16 | A-Award | 0.99 | 2023-06-21 |
| COOPERSTONE BRENDA | director | 2023-06-16 | A-Award | 0.99 | 2023-06-21 |
| Farokhzad Omid | director | 2023-06-16 | A-Award | 0.99 | 2023-06-21 |
| BAYER HEALTHCARE LLC | 10 percent owner | 2022-06-08 | 0 | 2023-02-13 | |
| Lee Philip J | officer: Chief Technology Officer | 2023-02-01 | A-Award | 1.81 | 2023-02-02 |
| KNOBELMAN DEBORAH | officer: Chief Financial Officer | 2023-02-01 | A-Award | 1.81 | 2023-02-02 |
| Rajangam Kanya | officer: Chief Medical & Devt. Officer | 2023-02-01 | A-Award | 1.81 | 2023-02-02 |
| Lu Timothy K | director, officer: CEO and President | 2023-02-01 | A-Award | 1.81 | 2023-02-02 |
| KNOBELMAN DEBORAH | officer: Chief Financial Officer | 2022-10-03 | A-Award | 0 | 2022-10-04 |
| KNOBELMAN DEBORAH | officer: Chief Financial Officer | 2022-10-03 | A-Award | 0 | 2022-10-04 |
| Rajangam Kanya | officer: Chief Medical & Devt. Officer | 2022-07-18 | A-Award | 1.8 | 2022-07-20 |
| Rajangam Kanya | officer: Chief Medical & Devt. Officer | 2022-07-18 | A-Award | 0 | 2022-07-20 |
| Mathers Edward T | director | 2022-07-13 | A-Award | 1.75 | 2022-07-15 |
| Collins James J. | director | 2022-07-13 | A-Award | 1.75 | 2022-07-15 |
| Rajangam Kanya | officer | 2022-07-05 | 0 | 2022-07-15 | |
| Mathers Edward T | director: | 2022-07-13 | A-Award | 0 | 2022-07-15 |
| Farokhzad Omid | director: | 2022-07-13 | A-Award | 0 | 2022-07-15 |
| Berland Susan D | director: | 2022-07-13 | A-Award | 0 | 2022-07-15 |
| Collins James J. | director: | 2022-07-13 | A-Award | 0 | 2022-07-15 |
| Epstein David R | director: | 2022-07-13 | A-Award | 0 | 2022-07-15 |
| COOPERSTONE BRENDA | director: | 2022-07-13 | A-Award | 0 | 2022-07-15 |
| Mathers Edward T | director: | 2022-06-08 | 0 | 2022-06-15 | |
| New Enterprise Associates 15, L.P. | 10 percent owner | 2022-06-08 | 0 | 2022-06-15 | |
| New Enterprise Associates 15, L.P. | 10 percent owner | 2022-06-08 | 0 | 2022-06-15 | |
| Lee Philip J | officer: Chief Technology Officer | 2022-06-08 | 0 | 2022-06-15 | |
| Lee Philip J | officer: Chief Technology Officer | 2022-06-08 | 9.92 | 2022-06-15 | |
| Lee Philip J | officer: Chief Technology Officer | 2022-06-08 | 0 | 2022-06-15 | |
| Berland Susan D | director | 2022-06-08 | 7.87 | 2022-06-15 | |
| Collins James J. | director | 2022-06-08 | 0 | 2022-06-15 | |
| Collins James J. | director | 2022-06-08 | 7.47 | 2022-06-15 | |
| Collins James J. | director | 2022-06-08 | 0 | 2022-06-15 | |
| COOPERSTONE BRENDA | director | 2022-06-08 | 3.12 | 2022-06-15 | |
| KNOBELMAN DEBORAH | officer: Chief Financial Officer | 2022-06-08 | 7.87 | 2022-06-15 | |
| KNOBELMAN DEBORAH | officer: Chief Financial Officer | 2022-06-08 | 9.92 | 2022-06-15 | |
| Herberts Curt A. III | officer: Chief Operating Officer | 2022-06-08 | 0 | 2022-06-15 | |
| Herberts Curt A. III | officer: Chief Operating Officer | 2022-06-08 | 9.92 | 2022-06-15 | |
| Herberts Curt A. III | officer: Chief Operating Officer | 2022-06-08 | 0 | 2022-06-15 |